Cargando…
Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies
Study participants were asked about their interest in switching to novel drug delivery systems that reduce the dosing frequency of antiretroviral regimens. Across a diverse, treatment-experienced cohort, we describe greatest interest in switching to an oral regimen taken once weekly, followed by inj...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197380/ https://www.ncbi.nlm.nih.gov/pubmed/30364593 http://dx.doi.org/10.1093/ofid/ofy247 |
_version_ | 1783364754458279936 |
---|---|
author | Derrick, Caroline B Ostermann, Jan Weissman, Sharon B Hobbie, Amy Alshareef, Noor Weinhold, Andrew Yelverton, Valerie Thielman, Nathan M |
author_facet | Derrick, Caroline B Ostermann, Jan Weissman, Sharon B Hobbie, Amy Alshareef, Noor Weinhold, Andrew Yelverton, Valerie Thielman, Nathan M |
author_sort | Derrick, Caroline B |
collection | PubMed |
description | Study participants were asked about their interest in switching to novel drug delivery systems that reduce the dosing frequency of antiretroviral regimens. Across a diverse, treatment-experienced cohort, we describe greatest interest in switching to an oral regimen taken once weekly, followed by injections taken every other month and twice-annual implants. |
format | Online Article Text |
id | pubmed-6197380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-61973802018-10-25 Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies Derrick, Caroline B Ostermann, Jan Weissman, Sharon B Hobbie, Amy Alshareef, Noor Weinhold, Andrew Yelverton, Valerie Thielman, Nathan M Open Forum Infect Dis Brief Report Study participants were asked about their interest in switching to novel drug delivery systems that reduce the dosing frequency of antiretroviral regimens. Across a diverse, treatment-experienced cohort, we describe greatest interest in switching to an oral regimen taken once weekly, followed by injections taken every other month and twice-annual implants. Oxford University Press 2018-10-22 /pmc/articles/PMC6197380/ /pubmed/30364593 http://dx.doi.org/10.1093/ofid/ofy247 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Report Derrick, Caroline B Ostermann, Jan Weissman, Sharon B Hobbie, Amy Alshareef, Noor Weinhold, Andrew Yelverton, Valerie Thielman, Nathan M Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies |
title | Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies |
title_full | Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies |
title_fullStr | Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies |
title_full_unstemmed | Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies |
title_short | Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies |
title_sort | who wants to switch? gauging patient interest in novel antiretroviral therapies |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197380/ https://www.ncbi.nlm.nih.gov/pubmed/30364593 http://dx.doi.org/10.1093/ofid/ofy247 |
work_keys_str_mv | AT derrickcarolineb whowantstoswitchgaugingpatientinterestinnovelantiretroviraltherapies AT ostermannjan whowantstoswitchgaugingpatientinterestinnovelantiretroviraltherapies AT weissmansharonb whowantstoswitchgaugingpatientinterestinnovelantiretroviraltherapies AT hobbieamy whowantstoswitchgaugingpatientinterestinnovelantiretroviraltherapies AT alshareefnoor whowantstoswitchgaugingpatientinterestinnovelantiretroviraltherapies AT weinholdandrew whowantstoswitchgaugingpatientinterestinnovelantiretroviraltherapies AT yelvertonvalerie whowantstoswitchgaugingpatientinterestinnovelantiretroviraltherapies AT thielmannathanm whowantstoswitchgaugingpatientinterestinnovelantiretroviraltherapies |